Interestingly, this group found that miR30a/c-5p directly targets DNMT1 3′UTR, inhibiting its expression and directing a feedback loop that uncovers additional mechanisms in ovarian cancer drug resistance. The gene discussed is DNMT1; the disease is ovarian carcinoma.